MedMira Gets U.S. FDA Approval on Fast HIV Test
October 24, 2006
On Thursday, Canada-based MedMira Inc. announced its Reveal rapid HIV-1 antibody test had received approval from the U.S. Food and Drug Administration. Previous versions of the test received FDA approval in 2003 and 2004; the latest version of the test, Reveal G3, delivers results in less than three minutes, the company said. The new version replaces a colorimetric detection agent used to visualize results on the test cartridge, thereby eliminating the need for reconstitution and refrigeration.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.